ENZN Stock Ownership Activity

ENZON PHARMACEUTICALS INC 13F holders

No value investing guru has made any change to the ENZON PHARMACEUTICALS INC (ENZN) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying ENZN now?

According to the latest SEC filing(s) ENZON PHARMACEUTICALS INC (ENZN) has not been purchased by any super investor.

To see more about who is investing in ENZON PHARMACEUTICALS INC (ENZN), please go to the ENZN ownership page.

2016 Q2 (1 result)
Carl Icahn
-100.00%
-5,904,863
-0.01%
0.00%
Current price: $0.08 82.98% Reported price*: $0.47
2014 Q1 (1 result)
Seth Klarman
-100.00%
-2,494,268
-0.12%
0.00%
Current price: $0.08 93.10% Reported price*: $1.16
2013 Q4 (1 result)
Seth Klarman
-43.60%
-1,928,317
-0.11%
0.00%
Current price: $0.08 93.10% Reported price*: $1.16
2013 Q2 (2 results)
Carl Icahn
buy
+5,904,863
+0.05%
0.05%
Seth Klarman
buy
+7,691,453
+0.39%
0.39%
Current price: $0.08 96.00% AVG reported price*: $2.00
5 of 5

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.